Literature DB >> 6323749

In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate.

A J Dorner, B L Semler, R J Jackson, R Hanecak, E Duprey, E Wimmer.   

Abstract

The translation of poliovirus RNA in rabbit reticulocyte lysate was examined. Translation of poliovirus RNA in this cell-free system resulted in an electrophoretic profile of poliovirus-specific proteins distinct from that observed in vivo or after translation in poliovirus-infected HeLa cell extract. A group of proteins derived from the P3 region of the polyprotein was identified by immunoprecipitation, time course, and N-formyl-[35S]methionine labeling studies to be the product of the initiation of protein synthesis at an internal site(s) located within the 3'-proximal RNA sequences. Utilization of this internal initiation site(s) on poliovirus RNA was abolished when reticulocyte lysate was supplemented with poliovirus-infected HeLa cell extract. Authentic P1-1a was also synthesized in reticulocyte lysate, indicating that correct 5'-proximal initiation of translation occurs in that system. We conclude that the deficiency of a component(s) of the reticulocyte lysate necessary for 5'-proximal initiation of poliovirus protein synthesis resulted in the ability of ribosomes to initiate translation on internal sequences. This aberrant initiation could be corrected by factors present in the HeLa cell extract. Apparently, under certain conditions, ribosomes are capable of recognizing internal sequences as authentic initiation sites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323749      PMCID: PMC255658     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Translation of poliovirus RNA in vitro: detection of two different initiation sites.

Authors:  M L Celma; E Ehrenfeld
Journal:  J Mol Biol       Date:  1975-11-15       Impact factor: 5.469

2.  Cell-free synthesis and processing of the proteins of poliovirus.

Authors:  D S Shih; C T Shih; O Kew; M Pallansch; R Rueckert; P Kaesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

3.  Gene order of the poliovirus capsid proteins.

Authors:  D Rekosh
Journal:  J Virol       Date:  1972-03       Impact factor: 5.103

4.  Determination of the gene sequence of poliovirus with pactamycin.

Authors:  D F Summers; J V Maizel
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

5.  Effect of pactamycin on synthesis of poliovirus proteins: a method for genetic mapping.

Authors:  R Taber; D Rekosh; D Baltimore
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

6.  Further evidence on the formation of poliovirus proteins.

Authors:  M F Jacobson; J Asso; D Baltimore
Journal:  J Mol Biol       Date:  1970-05-14       Impact factor: 5.469

7.  Polypeptide cleavages in the formation of poliovirus proteins.

Authors:  M F Jacobson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1968-09       Impact factor: 11.205

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Conversion of pre-proparathyroid hormone to proparathyroid hormone by dog pancreatic microsomes.

Authors:  A J Dorner; B Kemper
Journal:  Biochemistry       Date:  1978-12-12       Impact factor: 3.162

10.  Complete translation of poliovirus RNA in a eukaryotic cell-free system.

Authors:  L Villa-Komaroff; N Guttman; D Baltimore; H F Lodishi
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

View more
  109 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  A cell cycle-dependent protein serves as a template-specific translation initiation factor.

Authors:  E V Pilipenko; T V Pestova; V G Kolupaeva; E V Khitrina; A N Poperechnaya; V I Agol; C U Hellen
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

3.  Construction of regulatable picornavirus IRESes as a test of current models of the mechanism of internal translation initiation.

Authors:  T A Pöyry; M W Hentze; R J Jackson
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

4.  Cap-independent translation by the 5' untranslated region of Theiler's murine encephalomyelitis virus.

Authors:  P K Bandyopadhyay; C Wang; H L Lipton
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

5.  Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5' noncoding region.

Authors:  J R Gebhard; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus.

Authors:  W P Kong; R P Roos
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Conservation of RNA-protein interactions among picornaviruses.

Authors:  S L Dildine; B L Semler
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

8.  Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220.

Authors:  C U Hellen; M Fäcke; H G Kräusslich; C K Lee; E Wimmer
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

9.  Construction and genetic analysis of dicistronic polioviruses containing open reading frames for epitopes of human immunodeficiency virus type 1 gp120.

Authors:  H H Lu; L Alexander; E Wimmer
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro.

Authors:  Mauro Costa-Mattioli; Yuri Svitkin; Nahum Sonenberg
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.